Alnylam Pharmaceuticals: Q2 Earnings Insights

Alnylam Pharmaceuticals ALNY reported its Q2 earnings results on Thursday, July 28, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Alnylam Pharmaceuticals missed estimated earnings by 25.31%, reporting an EPS of $-2.03 versus an estimate of $-1.62.

Revenue was up $4.26 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.35 which was followed by a 6.8% drop in the share price the next day.

Here's a look at Alnylam Pharmaceuticals's past performance:

To track all earnings releases for Alnylam Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.